Fluocinonide Gel Recalled for Manufacturing Process Deviations
Teligent Pharma, Inc. is recalling all Fluocinonide Gel USP 0.05% nationwide within expiration date due to manufacturing deviations related to discontinued stability studies.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II precautionary recall due to cGMP deviations and the firm's discontinuation of stability studies. No illnesses or injuries have been reported. Per the rubric, voluntary precautionary recalls are scored as Moderate.
Plain-English summary
Teligent Pharma, Inc. is recalling all Fluocinonide Gel USP, 0.05%, that remain within their expiration dates. The product is packaged in 15 g, 30 g, and 60 g tubes under three NDC numbers. The recall is due to current Good Manufacturing Practice (cGMP) deviations: the manufacturing firm is discontinuing its stability study program for this product.
The affected product was distributed nationwide in the USA and Puerto Rico. A total of 51,748 tubes are subject to this recall.
Consumers who have this product should discontinue use and consult their healthcare provider regarding alternative treatment options. Affected patients should follow Teligent Pharma's instructions for product return and disposal.
The recalled product
- Product
- Fluocinonide Gel USP, 0.05%, packaged in a) 15 g tubes, NDC 52565-054-15; b) 60 g tubes, NDC 52565-054-60; c) 30 g tubes, NDC 52565-054-30, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Affected units
- 51,748
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Batch: a) 15122
- Exp. 2/28/2022
- 15475
- Exp. 3/31/2022
- b) 15119
- 15122
- 15380
- c) 15380
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · stability issue
See all →- Moderate5-PLASMA Bivalirudin Control Model 5D-44905 Recalled Due to Stability Issues
FDA (Devices) · 2026-08-12
- ModerateAniara 5-PLASMA Bivalirudin Calibrator Recalled for Stability Issues
FDA (Devices) · 2026-08-12
- HighInjectable Drug Recalled for Stability Issues at Expiration
FDA (Drugs) · 2025-03-26
- ModerateMedline Bleach Germicidal Wipes Recalled for Incorrect Shelf-Life Labeling
FDA (Devices) · 2024-02-28
- ModerateZydus oxybutynin extended-release tablets recalled nationwide for failed stability testing
FDA (Drugs) · 2023-11-15